Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Acta Haematologica|April 19, 2019
"Mixed" Myeloproliferative Neoplasm Due to Co-Occurrence of Different Driver MutationsIsabelle Plo
Blood|August 2, 2014
p53 at the crossroads of MPN treatmentIsabelle Plo
Blood|December 27, 2019
Not just another kinase mutation!Isabelle Plo, Caroline Marty
Blood|January 21, 2017
P53 deletion and NrasG12D cooperate for AMLWilliam Vainchenker, Isabelle Plo
Blood|July 24, 2025
Dissecting JAK2V617F's double life with and without MPLIsabelle Plo, Caroline Marty
Clinical Lymphoma & Myeloma|September 26, 2009
Molecular and genetic bases of myeloproliferative disorders: questions and perspectivesIsabelle Plo, William Vainchenker
Blood|January 21, 2021
IFN: Jekyll and HydeIsabelle Plo, William Vainchenker
Blood|January 10, 2015
TET2 loss, a rescue of JAK2V617F HSCsWilliam Vainchenker, Isabelle Plo
Blood|July 2, 2016
EZH2: a molecular switch of the MPN phenotypeWilliam Vainchenker, Isabelle Plo
Haematologica|July 20, 2023
The double-edged sword of adenosineIsabelle Plo, Iléana Antony-Debré
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Acta Haematologica|April 19, 2019
"Mixed" Myeloproliferative Neoplasm Due to Co-Occurrence of Different Driver MutationsIsabelle Plo
Blood|August 2, 2014
p53 at the crossroads of MPN treatmentIsabelle Plo
Blood|December 27, 2019
Not just another kinase mutation!Isabelle Plo, Caroline Marty
Blood|January 21, 2017
P53 deletion and NrasG12D cooperate for AMLWilliam Vainchenker, Isabelle Plo
Blood|July 24, 2025
Dissecting JAK2V617F's double life with and without MPLIsabelle Plo, Caroline Marty
Clinical Lymphoma & Myeloma|September 26, 2009
Molecular and genetic bases of myeloproliferative disorders: questions and perspectivesIsabelle Plo, William Vainchenker
Blood|January 21, 2021
IFN: Jekyll and HydeIsabelle Plo, William Vainchenker
Blood|January 10, 2015
TET2 loss, a rescue of JAK2V617F HSCsWilliam Vainchenker, Isabelle Plo
Blood|July 2, 2016
EZH2: a molecular switch of the MPN phenotypeWilliam Vainchenker, Isabelle Plo
Haematologica|July 20, 2023
The double-edged sword of adenosineIsabelle Plo, Iléana Antony-Debré
Pageof 13